PMC10361752_01
(i) pericarbon MORE surgical bioprosthetic valve (ii) hancock II surgical bioprosthetic valve.
fcvm-10-1152280-g001.jpg
PMC10361752_05_fcvm-10-1152280-g001.jpg
F1
Almost 17 years later, the patient developed symptomatic mitral stenosis and tricuspid regurgitation requiring surgical replacement of both valves {mechanical prosthesis Carbomedics 27 mm in mitral position and Pericarbon More 29 mm in tricuspid position [Figure 1(ii)].
Represents fluoroscopic imaging after VIV implantation of all 5 patients (case 1 to case 5).
fcvm-10-1152280-g002.jpg
PMC10361752_05_fcvm-10-1152280-g002.jpg
F2
Sciences Pvt. Ltd., India), the BE Myval THV was successfully implanted, without pacing (Table 1, Figures 2: 5A,B) but three hours after the procedure, due to moderate femoral vein bleeding, two units of packed red blood cells were transfused, and surgical intervention was needed to manage this complication. Seven days after the procedure, the patient was discharged on anticoagulant therapy (VKA) (Table 2).
PMC10361752_02
(i) pericarbon MORE surgical bioprosthetic valve (ii) hancock II surgical bioprosthetic valve.
fcvm-10-1152280-g001.jpg
PMC10361752_05_fcvm-10-1152280-g001.jpg
F1
Almost 17 years later, the patient developed symptomatic mitral stenosis and tricuspid regurgitation requiring surgical replacement of both valves {mechanical prosthesis Carbomedics 27 mm in mitral position and Pericarbon More 29 mm in tricuspid position [Figure 1(ii)].
Represents fluoroscopic imaging after VIV implantation of all 5 patients (case 1 to case 5).
fcvm-10-1152280-g002.jpg
PMC10361752_05_fcvm-10-1152280-g002.jpg
F2
Sciences Pvt. Ltd., India), the BE Myval THV was successfully implanted, without pacing (Table 1, Figures 2: 5A,B) but three hours after the procedure, due to moderate femoral vein bleeding, two units of packed red blood cells were transfused, and surgical intervention was needed to manage this complication. Seven days after the procedure, the patient was discharged on anticoagulant therapy (VKA) (Table 2).
PMC10361752_03
(i) pericarbon MORE surgical bioprosthetic valve (ii) hancock II surgical bioprosthetic valve.
fcvm-10-1152280-g001.jpg
PMC10361752_05_fcvm-10-1152280-g001.jpg
F1
Almost 17 years later, the patient developed symptomatic mitral stenosis and tricuspid regurgitation requiring surgical replacement of both valves {mechanical prosthesis Carbomedics 27 mm in mitral position and Pericarbon More 29 mm in tricuspid position [Figure 1(ii)].
Represents fluoroscopic imaging after VIV implantation of all 5 patients (case 1 to case 5).
fcvm-10-1152280-g002.jpg
PMC10361752_05_fcvm-10-1152280-g002.jpg
F2
Sciences Pvt. Ltd., India), the BE Myval THV was successfully implanted, without pacing (Table 1, Figures 2: 5A,B) but three hours after the procedure, due to moderate femoral vein bleeding, two units of packed red blood cells were transfused, and surgical intervention was needed to manage this complication. Seven days after the procedure, the patient was discharged on anticoagulant therapy (VKA) (Table 2).
PMC10361752_04
(i) pericarbon MORE surgical bioprosthetic valve (ii) hancock II surgical bioprosthetic valve.
fcvm-10-1152280-g001.jpg
PMC10361752_05_fcvm-10-1152280-g001.jpg
F1
Almost 17 years later, the patient developed symptomatic mitral stenosis and tricuspid regurgitation requiring surgical replacement of both valves {mechanical prosthesis Carbomedics 27 mm in mitral position and Pericarbon More 29 mm in tricuspid position [Figure 1(ii)].
Represents fluoroscopic imaging after VIV implantation of all 5 patients (case 1 to case 5).
fcvm-10-1152280-g002.jpg
PMC10361752_05_fcvm-10-1152280-g002.jpg
F2
Sciences Pvt. Ltd., India), the BE Myval THV was successfully implanted, without pacing (Table 1, Figures 2: 5A,B) but three hours after the procedure, due to moderate femoral vein bleeding, two units of packed red blood cells were transfused, and surgical intervention was needed to manage this complication. Seven days after the procedure, the patient was discharged on anticoagulant therapy (VKA) (Table 2).
PMC10361752_05
(i) pericarbon MORE surgical bioprosthetic valve (ii) hancock II surgical bioprosthetic valve.
fcvm-10-1152280-g001.jpg
PMC10361752_05_fcvm-10-1152280-g001.jpg
F1
Almost 17 years later, the patient developed symptomatic mitral stenosis and tricuspid regurgitation requiring surgical replacement of both valves {mechanical prosthesis Carbomedics 27 mm in mitral position and Pericarbon More 29 mm in tricuspid position [Figure 1(ii)].
Represents fluoroscopic imaging after VIV implantation of all 5 patients (case 1 to case 5).
fcvm-10-1152280-g002.jpg
PMC10361752_05_fcvm-10-1152280-g002.jpg
F2
Sciences Pvt. Ltd., India), the BE Myval THV was successfully implanted, without pacing (Table 1, Figures 2: 5A,B) but three hours after the procedure, due to moderate femoral vein bleeding, two units of packed red blood cells were transfused, and surgical intervention was needed to manage this complication. Seven days after the procedure, the patient was discharged on anticoagulant therapy (VKA) (Table 2).